Merck will initiate interferon-free Phase II clinical trials for MK-5172
2 November 2012 | By Merck
Merck announced plans to initiate two new clinical trials with MK-5172...
List view / Grid view
News
Amgen to present data from four Phase 2 studies at upcoming American Heart Association Scientific Sessions 2012
2 November 2012 | By Amgen
Amgen to present data from four Phase 2 trials...
Abbott and the Abbott Fund donate $1 million in funding and products to support Hurricane Sandy relief efforts
2 November 2012 | By Abbott
Abbott and its foundation are providing $1 million in funding and product donations...
GSK announces FDA Advisory Committee vote in favour of raxibacumab for the treatment of inhalational anthrax infection
2 November 2012 | By GlaxoSmithKline
Anthrax has been identified as a serious potential threat...
Portola, Bristol-Myers Squibb and Pfizer sign clinical collaboration agreement
1 November 2012 | By Bristol-Myers Squibb Company
Portola Pharmaceuticals, Inc., Bristol-Myers Squibb Company and Pfizer announced a clinical collaboration agreement...
Data in NEJM show Novartis drug Aclasta® significantly reduced the risk of fracture in men with osteoporosis with once-yearly infusion
1 November 2012 | By Edelman
NEJM published results...
More than £1 billion to be invested in UK science and research
1 November 2012 | By BIS Press Office
New science investment will make sure UK competes and thrives in global race...
Bristol-Myers Squibb receives positive decision from NICE for YERVOY® (ipilimumab)
1 November 2012 | By Bristol-Myers Squibb Company
NICE has decided to recommend YERVOY®...
GSK supports BMJ commitment on clinical trial data transparency
31 October 2012 | By GlaxoSmithKline
“GSK fully supports the commitment made by BMJ to drive greater transparency of clinical trial data..."
Wealth of worldwide evidence on Pradaxa® including first clinical data on long-term efficacy and safety of a novel oral anticoagulant to be presented
31 October 2012 | By Boehringer Ingelheim
Results from RELY-ABLE®...
Novo Nordisk increased operating profit by 34% in the first nine months of 2012
31 October 2012 | By Novo Nordisk
Sales grew 18% driven by Victoza®, NovoRapid® and Levemir®...
Roche medicine Avastin receives EU approval for the treatment of women with recurrent, platinum-sensitive ovarian cancer
31 October 2012 | By Roche
The EC has approved Avastin...
Novartis to start construction of new biotechnology facility in Singapore with an investment of over USD 500 million
31 October 2012 | By Novartis
Novartis announced the construction of a new state-of-the-art biotechnology production site...
Boehringer Ingelheim presents robust pipeline highlighting its Respiratory R&D
31 October 2012 | By Boehringer Ingelheim
Patients and physicians may have several innovative respiratory treatments available in the coming years...
Alzheimer’s, cancer and rare disease research to benefit from landmark MRC-AstraZeneca compound collaboration
31 October 2012 | By AstraZeneca
Funding for 15 research projects...
